Navigation Links
Beckman Coulter to Acquire Flow Cytometry Instrumentation Business From Dako

Highly-Regarded Research Flow Cytometry Portfolio Targeted at Fast Growing

Market Segment

FULLERTON, Calif., and GLOSTRUP, Denmark, Nov. 19 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading developer of products that simplify and automate complex biomedical testing, and Dako Denmark A/S, a world leader in cancer diagnostics, announced today that Beckman Coulter will acquire Dako's research flow cytometry instrumentation business, which is based in Fort Collins, Colorado. Financial terms were not disclosed.


Scott Garrett, Beckman Coulter's president and chief executive officer, said, "We are enthusiastic about the opportunity to add Dako's MoFlo XDP high-performance sorter, the gold standard for cell sorting, and the highly capable nine-color CyAn research flow cytometer to our existing portfolio of cytometry instruments. This transaction allows us to offer a more comprehensive range of research solutions to our customers."

Dako's president and CEO, Patrik Dahlen, said, "This action reinforces our strategic intent to create a more focused business in anatomic pathology and tissue-based cancer diagnostics. We believe our flow cytometry instrumentation products are an excellent match for Beckman Coulter and will achieve even greater success when combined with the company's existing flow cytometry infrastructure and reputation for quality, service and support."

Dako's flow cytometry instrument business workforce of almost 200 people includes sales, marketing, research, manufacturing and administrative personnel. Flow cytometry is used to analyze cells in blood and other fluids for both research applications and diagnosis of diseases such as leukemia, lymphoma and HIV.

Garrett added, "I want to welcome the talented people transferring to us from Dako. We see significant opportunities for Beckman Coulter in flow cytometry and continue to expand our investment in this fast-growing market segment."

The transaction is expected to close by the end of the year. More information about the transaction will be available during Beckman Coulter's 2007 Annual Business Review meeting on December 11. Contact Investor Relations for details.

About Dako

Dako, which is headquartered in Denmark, strives to improve tissue-based cancer diagnostics focusing on the workflow in the pathology laboratory. The company develops and markets instruments, reagents and software that will reduce time from biopsy to diagnosis, improve the quality and reliability of diagnosis, and increase efficiency in the lab. For information, visit

About Beckman Coulter, Inc.

Based in Fullerton, California, Beckman Coulter develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue consisting of supplies, test kits, service and operating-type lease payments represents more than 75 percent of the company's 2006 annual revenue of $2.53 billion. For more information, visit

Forward Looking Statements

This press release contains forward-looking statements, including statements regarding the contribution of the acquisition to Beckman Coulter's R&D and product development capability. These statements are based on current expectations and assumptions. Actual results could differ materially from those anticipated by these forward-looking statements as a result of a number of factors, some of which may be beyond Beckman Coulter's control. Beckman Coulter disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Contacts: Mary Luthy, Beckman Coulter Robert Raynor, Beckman Coulter

Corporate Communications Investor Relations

(714) 773-7964 (714) 773-7620

Leif Norgaard, Dako Group

Chief Financial Officer

+45 2088 7280

SOURCE Beckman Coulter, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Beckman Coulter Announces Licensing Option Agreements for Cancer Genes with Johns Hopkins University
2. Beckman Coulter Signs Agreements With Amerinet, Inc.; Ten-Year Partnership Extended for Another Three Years
3. Beckman Coulter to Present at the Credit Suisse Global Healthcare Conference
4. Cogdell Spencer Inc. Acquires Summit Professional Plaza I and II in Brunswick, Georgia
5. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
6. Food Bank For New York City Acquires FoodChange
7. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
8. AMERIGROUP to Acquire Memphis Health Plan
9. Concentra Acquires Assets of Renew Health & Wellness
10. DaVita Acquires Majority Stake in HomeChoice Partners, Inc.
11. NNN Healthcare/Office REIT Acquires St. Mary Physicians Center in Long Beach, California
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... Florida Hospital Tampa is the first health care provider ... state of Florida. , vBloc® Therapy is a vagal blocking therapy, delivered via the Maestro® ... body mass index (BMI) of at least 40 to 45 kg, or a BMI of ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. Paul Vitenas, one ... Surgery, has been named by MedEsthetics magazine as the Best Single Physician Practice in ... among the many elite aesthetic physicians honored by the industry publication. , Dr. ...
(Date:12/1/2015)... Delaware (PRWEB) , ... December 01, 2015 , ... ... winner at the 7th Annual 2015 Golden Bridge Business Awards under the New ... is a zero capex web based sample management software that helps ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... radiographic technicians must mark the film for accurate interpretation by the radiologist. The ... Fortunately, an inventor from Sacramento, Calif., has found a way to alleviate this ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... it has been awarded a fixed price per sprint agile development contract to ... at $34 million over five years, provides software engineering, infrastructure, as well as ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Dec. 1, 2015 WellStar Health System has ... Texas -based Tenet Healthcare,s five metro ... approved the strategic move following the conclusion of the ... clinical care models and patient safety programs that have ... to new communities. --> ...
(Date:12/1/2015)... , Dec. 1, 2015  Eyeon Therapeutics has ... dry eye treatments based on a charged hydrophilic ... delivery CDMO.  The product has been shown to ... previously published.  Mark Mitchnick , MD, CEO ... protection to additional polymers in conjunction with a ...
(Date:12/1/2015)... 1, 2015 Pharma Tech Outlook recently conducted ... Clinical Data Management Solution Providers - 2015 .  After ... comprising CEOs, CIOs, VCs, analysts, and the Pharma Tech ... of top 10 clinical data management solution providers (check ... 14 and 36 respectively). --> ...
Breaking Medicine Technology: